|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current assets | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Total current assets | ||||||
| Cash and marketable securities held in trust account | ||||||
| TOTAL ASSETS | ||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||
| Current liabilities | ||||||
| Accrued expenses | ||||||
| Accrued offering costs | ||||||
| Income taxes payable | ||||||
| Total current liabilities | ||||||
| Convertible note - related party | ||||||
| Deferred tax liability | ||||||
| Deferred underwriting fee payable | ||||||
| Total Liabilities | ||||||
| Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 28,750,000 shares subject to redemption at redemption value as of December 31, 2022 and 2021 | ||||||
| Stockholders’ Deficit | ||||||
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 7,187,500 shares issued and outstanding as of December 31, 2022 and 2021 | ||||||
| Accumulated deficit | ||||||
| Total Stockholders’ Deficit | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
Loading...
